$RPTP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HORIZON PHARMACEUTICAL LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HORIZON PHARMACEUTICAL LLC. Get notifications about new insider transactions in HORIZON PHARMACEUTICAL LLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | D | 5.49 | 30,680 | 168,433 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | D | 5.13 | 90,000 | 461,700 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Sell | U | 9.00 | 48,437 | 435,933 | 8,330 | 56.8 K to 8.3 K (-85.33 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Option Exercise | D | 5.22 | 7,915 | 41,316 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Sell | U | 9.00 | 2,092 | 18,828 | 8,330 | 10.4 K to 8.3 K (-20.07 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commercial Of ... | Option Exercise | D | 3.74 | 93,784 | 350,752 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commercial Of ... | Sell | D | 9.00 | 28,939 | 260,451 | 0 | 28.9 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commercial Of ... | Sell | U | 9.00 | 8,934 | 80,406 | 28,939 | 37.9 K to 28.9 K (-23.59 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Michael P | Chief Financial Off ... | Option Exercise | D | 3.74 | 84,751 | 316,969 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Michael P | Chief Financial Off ... | Sell | D | 9.00 | 22,607 | 203,463 | 0 | 22.6 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | Chief Legal Officer | Option Exercise | D | 3.74 | 44,054 | 164,762 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | Chief Legal Officer | Sell | D | 9.00 | 36,690 | 330,210 | 0 | 36.7 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | Chief Legal Officer | Sell | U | 9.00 | 9,286 | 83,574 | 36,690 | 46 K to 36.7 K (-20.20 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.22 | 7,915 | 41,316 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Sell | U | 9.00 | 2,092 | 18,828 | 8,330 | 10.4 K to 8.3 K (-20.07 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | D | 5.49 | 50,000 | 274,500 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | D | 5.13 | 120,000 | 615,600 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | D | 3.54 | 90,000 | 318,600 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | D | 2.97 | 30,000 | 89,100 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | U | 9.00 | 6,695 | 60,255 | 8,330 | 15 K to 8.3 K (-44.56 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 3.74 | 240,595 | 899,825 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 8.13 | 175,000 | 1,422,750 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | D | 5.27 | 152,050 | 801,304 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Sell | D | 9.00 | 64,179 | 577,611 | 0 | 64.2 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Sell | U | 9.00 | 45,759 | 411,831 | 64,179 | 109.9 K to 64.2 K (-41.62 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | D | 5.49 | 50,000 | 274,500 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | D | 5.13 | 120,000 | 615,600 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | D | 3.54 | 74,164 | 262,541 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Sell | U | 9.00 | 6,695 | 60,255 | 8,330 | 15 K to 8.3 K (-44.56 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | D | 5.49 | 50,000 | 274,500 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | D | 5.13 | 120,000 | 615,600 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | D | 3.54 | 90,000 | 318,600 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Sell | U | 9.00 | 6,695 | 60,255 | 8,330 | 15 K to 8.3 K (-44.56 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | D | 5.49 | 150,000 | 823,500 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | D | 5.13 | 460,064 | 2,360,128 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | D | 9.00 | 8,330 | 74,970 | 0 | 8.3 K to 0 (-100.00 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | U | 9.00 | 706,065 | 6,354,585 | 8,330 | 714.4 K to 8.3 K (-98.83 %) |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Polu Krishna R | Chief Medical Offic ... | Option Exercise | D | 3.74 | 89,152 | 333,428 | 0 | |
Oct 26 2016 | RPTP | Raptor Pharmaceuti ... | Polu Krishna R | Chief Medical Offic ... | Sell | D | 9.00 | 23,781 | 214,029 | 0 | 23.8 K to 0 (-100.00 %) |
Sep 23 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | Chief Legal Officer | Payment of Exercise | F | 6.02 | 3,125 | 18,813 | 45,976 | 49.1 K to 46 K (-6.36 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Grant | A | 0.00 | 8,330 | 0 | 714,395 | 706.1 K to 714.4 K (+1.18 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Grant | A | 0.00 | 8,330 | 0 | 10,422 | 2.1 K to 10.4 K (+398.18 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Grant | A | 0.00 | 8,330 | 0 | 10,422 | 2.1 K to 10.4 K (+398.18 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Grant | A | 0.00 | 8,330 | 0 | 15,025 | 6.7 K to 15 K (+124.42 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Grant | A | 0.00 | 8,330 | 0 | 15,025 | 6.7 K to 15 K (+124.42 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Grant | A | 0.00 | 8,330 | 0 | 56,767 | 48.4 K to 56.8 K (+17.20 %) |
Jun 27 2016 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Grant | A | 0.00 | 8,330 | 0 | 15,025 | 6.7 K to 15 K (+124.42 %) |
Mar 03 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commerical Of ... | Payment of Exercise | F | 3.43 | 576 | 1,977 | 29,670 | 30.2 K to 29.7 K (-1.90 %) |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Polu Krishna R | Chief Medical Offic ... | Option Exercise | A | 3.74 | 89,152 | 333,428 | 89,152 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Polu Krishna R | Chief Medical Offic ... | Grant | A | 0.00 | 23,781 | 0 | 23,781 | 0 to 23.8 K |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commerical Of ... | Option Exercise | A | 3.74 | 93,784 | 350,752 | 93,784 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commerical Of ... | Grant | A | 0.00 | 25,017 | 0 | 30,246 | 5.2 K to 30.2 K (+478.43 %) |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | SVP Gen Counsel-Cor ... | Option Exercise | A | 3.74 | 44,054 | 164,762 | 44,054 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | SVP Gen Counsel-Cor ... | Grant | A | 0.00 | 11,751 | 0 | 45,003 | 33.3 K to 45 K (+35.34 %) |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Michael P | Chief Financial Off ... | Option Exercise | A | 3.74 | 84,751 | 316,969 | 84,751 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Michael P | Chief Financial Off ... | Grant | A | 0.00 | 22,607 | 0 | 22,607 | 0 to 22.6 K |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Option Exercise | A | 3.74 | 240,595 | 899,825 | 240,595 | |
Feb 11 2016 | RPTP | Raptor Pharmaceuti ... | Smith Julie | President and CEO | Grant | A | 0.00 | 64,179 | 0 | 102,129 | 38 K to 102.1 K (+169.11 %) |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 5.22 | 7,915 | 41,316 | 7,915 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | LAPOINTE ANTHONY GREGG | Director | Grant | A | 0.00 | 2,092 | 0 | 2,092 | 0 to 2.1 K |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Option Exercise | A | 5.22 | 7,915 | 41,316 | 7,915 | |
Apr 19 2016 | RPTP | Raptor Pharmaceuti ... | GEMAYEL GEORGES | Director | Grant | A | 0.00 | 2,092 | 0 | 2,092 | 0 to 2.1 K |
Sep 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | M | 5.13 | 15,000 | 76,950 | 0 | |
Sep 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | M | 3.33 | 45,000 | 149,850 | 0 | |
Sep 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Sell | S | 12.47 | 18,258 | 227,730 | 48,437 | 66.7 K to 48.4 K (-27.38 %) |
Sep 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Buy | M | 5.13 | 15,000 | 76,950 | 66,695 | 51.7 K to 66.7 K (+29.02 %) |
Sep 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Buy | M | 3.33 | 45,000 | 149,850 | 51,695 | 6.7 K to 51.7 K (+672.14 %) |
Sep 04 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.02 | 4,916 | 9,930 | 0 | |
Sep 04 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 12.51 | 4,916 | 61,489 | 6,695 | 11.6 K to 6.7 K (-42.34 %) |
Sep 04 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.02 | 4,916 | 9,930 | 11,611 | 6.7 K to 11.6 K (+73.43 %) |
Sep 02 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.02 | 8,084 | 16,330 | 4,916 | |
Sep 02 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 12.52 | 8,084 | 101,192 | 6,695 | 14.8 K to 6.7 K (-54.70 %) |
Sep 02 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.02 | 8,084 | 16,330 | 14,779 | 6.7 K to 14.8 K (+120.75 %) |
Jul 29 2015 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | SVP Gen Counsel-Cor ... | Option Exercise | A | 13.77 | 115,500 | 1,590,435 | 115,500 | |
Jul 29 2015 | RPTP | Raptor Pharmaceuti ... | Gould Ashley C. | SVP Gen Counsel-Cor ... | Grant | A | 0.00 | 33,252 | 0 | 33,252 | 0 to 33.3 K |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 3.54 | 15,836 | 56,059 | 74,164 | |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 2.97 | 29,490 | 87,585 | 0 | |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 2.02 | 2,488 | 5,026 | 0 | |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 3.30 | 2,186 | 7,214 | 0 | |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Sell | S | 16.05 | 50,000 | 802,545 | 6,695 | 56.7 K to 6.7 K (-88.19 %) |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 3.54 | 15,836 | 56,059 | 56,695 | 40.9 K to 56.7 K (+38.76 %) |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 2.97 | 29,490 | 87,585 | 40,859 | 11.4 K to 40.9 K (+259.39 %) |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 2.02 | 2,488 | 5,026 | 11,369 | 8.9 K to 11.4 K (+28.01 %) |
Jul 02 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 3.30 | 2,186 | 7,214 | 8,881 | 6.7 K to 8.9 K (+32.65 %) |
Jun 22 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Option Exercise | M | 3.54 | 5,000 | 17,700 | 62,864 | |
Jun 22 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Sell | S | 15.00 | 5,000 | 75,000 | 34,719 | 39.7 K to 34.7 K (-12.59 %) |
Jun 22 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Buy | M | 3.54 | 5,000 | 17,700 | 39,719 | 34.7 K to 39.7 K (+14.40 %) |
Jun 22 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Sell | S | 15.00 | 30,000 | 450,000 | 34,719 | 64.7 K to 34.7 K (-46.35 %) |
Jun 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | M | 3.33 | 30,000 | 99,900 | 45,000 | |
Jun 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Sell | S | 13.45 | 30,000 | 403,422 | 6,695 | 36.7 K to 6.7 K (-81.76 %) |
Jun 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Buy | M | 3.33 | 30,000 | 99,900 | 36,695 | 6.7 K to 36.7 K (+448.10 %) |
May 22 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Sell | S | 12.00 | 10,000 | 120,000 | 64,719 | 74.7 K to 64.7 K (-13.38 %) |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | A | 11.55 | 18,996 | 219,404 | 18,996 | |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Grant | A | 0.00 | 5,021 | 0 | 706,065 | 701 K to 706.1 K (+0.72 %) |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 11.55 | 18,996 | 219,404 | 18,996 | |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Grant | A | 0.00 | 5,021 | 0 | 6,695 | 1.7 K to 6.7 K (+299.94 %) |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 11.55 | 18,996 | 219,404 | 18,996 | |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Grant | A | 0.00 | 5,021 | 0 | 6,695 | 1.7 K to 6.7 K (+299.94 %) |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 11.55 | 18,996 | 219,404 | 18,996 | |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Grant | A | 0.00 | 5,021 | 0 | 6,695 | 1.7 K to 6.7 K (+299.94 %) |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 11.55 | 18,996 | 219,404 | 18,996 | |
May 21 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Grant | A | 0.00 | 5,021 | 0 | 6,695 | 1.7 K to 6.7 K (+299.94 %) |
May 05 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | M | 2.97 | 10,000 | 29,700 | 0 | |
May 05 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Sell | S | 9.61 | 10,000 | 96,075 | 1,674 | 11.7 K to 1.7 K (-85.66 %) |
May 05 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Buy | M | 2.97 | 10,000 | 29,700 | 11,674 | 1.7 K to 11.7 K (+597.37 %) |
Apr 06 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | M | 2.97 | 10,000 | 29,700 | 10,000 | |
Apr 06 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Sell | S | 10.37 | 10,000 | 103,667 | 1,674 | 11.7 K to 1.7 K (-85.66 %) |
Apr 06 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Buy | M | 2.97 | 10,000 | 29,700 | 11,674 | 1.7 K to 11.7 K (+597.37 %) |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.02 | 2,000 | 4,040 | 13,000 | |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.57 | 8,306 | 21,346 | 0 | |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.57 | 11,313 | 29,074 | 0 | |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 12.00 | 21,619 | 259,428 | 1,674 | 23.3 K to 1.7 K (-92.81 %) |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.02 | 2,000 | 4,040 | 23,293 | 21.3 K to 23.3 K (+9.39 %) |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.57 | 8,306 | 21,346 | 21,293 | 13 K to 21.3 K (+63.96 %) |
Mar 26 2015 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.57 | 11,313 | 29,074 | 12,987 | 1.7 K to 13 K (+675.81 %) |
Mar 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | M | 3.54 | 20,033 | 70,917 | 0 | |
Mar 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | S | 11.62 | 20,033 | 232,725 | 701,044 | 721.1 K to 701 K (-2.78 %) |
Mar 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Buy | M | 3.54 | 20,033 | 70,917 | 721,077 | 701 K to 721.1 K (+2.86 %) |
Mar 18 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | M | 3.54 | 30,021 | 106,274 | 20,033 | |
Mar 18 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | S | 11.71 | 30,021 | 351,564 | 701,044 | 731.1 K to 701 K (-4.11 %) |
Mar 18 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Buy | M | 3.54 | 30,021 | 106,274 | 731,065 | 701 K to 731.1 K (+4.28 %) |
Mar 09 2015 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 10.71 | 25,000 | 267,703 | 4,005 | 29 K to 4 K (-86.19 %) |
Mar 03 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | M | 2.97 | 10,000 | 29,700 | 20,000 | |
Mar 03 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Sell | S | 9.18 | 10,000 | 91,847 | 0 | 10 K to 0 (-100.00 %) |
Mar 03 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Buy | M | 2.97 | 10,000 | 29,700 | 10,000 | 0 to 10 K |
Feb 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | M | 3.54 | 30,000 | 106,200 | 50,054 | |
Feb 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | S | 9.52 | 30,000 | 285,654 | 701,044 | 731 K to 701 K (-4.10 %) |
Feb 25 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Buy | M | 3.54 | 30,000 | 106,200 | 731,044 | 701 K to 731 K (+4.28 %) |
Feb 19 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | M | 3.54 | 30,000 | 106,200 | 80,054 | |
Feb 19 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Sell | S | 9.37 | 30,000 | 281,106 | 701,044 | 731 K to 701 K (-4.10 %) |
Feb 19 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Buy | M | 3.54 | 30,000 | 106,200 | 731,044 | 701 K to 731 K (+4.28 %) |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commercial Of ... | Option Exercise | A | 9.36 | 19,583 | 183,297 | 19,583 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Happel David | Chief Commercial Of ... | Grant | A | 0.00 | 5,229 | 0 | 5,229 | 0 to 5.2 K |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Option Exercise | A | 9.36 | 43,100 | 403,416 | 43,100 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Chief Business Offi ... | Grant | A | 0.00 | 11,500 | 0 | 74,719 | 63.2 K to 74.7 K (+18.19 %) |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Option Exercise | A | 9.36 | 6,332 | 59,268 | 6,332 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Director | Grant | A | 0.00 | 1,674 | 0 | 701,044 | 699.4 K to 701 K (+0.24 %) |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 9.36 | 6,332 | 59,268 | 6,332 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Grant | A | 0.00 | 1,674 | 0 | 29,005 | 27.3 K to 29 K (+6.12 %) |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 9.36 | 6,332 | 59,268 | 6,332 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Grant | A | 0.00 | 1,674 | 0 | 1,674 | 0 to 1.7 K |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 9.36 | 6,332 | 59,268 | 6,332 | |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Grant | A | 0.00 | 1,674 | 0 | 1,674 | 0 to 1.7 K |
Feb 11 2015 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 9.36 | 6,332 | 59,268 | 6,332 |